JPWO2022202537A1 - - Google Patents

Info

Publication number
JPWO2022202537A1
JPWO2022202537A1 JP2023509065A JP2023509065A JPWO2022202537A1 JP WO2022202537 A1 JPWO2022202537 A1 JP WO2022202537A1 JP 2023509065 A JP2023509065 A JP 2023509065A JP 2023509065 A JP2023509065 A JP 2023509065A JP WO2022202537 A1 JPWO2022202537 A1 JP WO2022202537A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023509065A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022202537A1 publication Critical patent/JPWO2022202537A1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2023509065A 2021-03-22 2022-03-16 Pending JPWO2022202537A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021047661 2021-03-22
PCT/JP2022/011917 WO2022202537A1 (ja) 2021-03-22 2022-03-16 含フッ素ピリミジン化合物およびその製造方法

Publications (1)

Publication Number Publication Date
JPWO2022202537A1 true JPWO2022202537A1 (ja) 2022-09-29

Family

ID=83396155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509065A Pending JPWO2022202537A1 (ja) 2021-03-22 2022-03-16

Country Status (4)

Country Link
EP (1) EP4317154A1 (ja)
JP (1) JPWO2022202537A1 (ja)
CN (1) CN117043158A (ja)
WO (1) WO2022202537A1 (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664908A (zh) * 2013-12-10 2014-03-26 苏州大学 一种具有腺苷受体拮抗活性的氨基嘧啶杂环化合物
CN107286146B (zh) 2017-07-05 2020-07-31 上海肇钰医药科技有限公司 作为腺苷a2a受体拮抗剂的4-氨基嘧啶衍生物及其用途
EP3892617A4 (en) * 2018-12-07 2022-08-31 Unimatec Co., Ltd. FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCTION THEREOF
JP7439124B2 (ja) * 2019-11-14 2024-02-27 ユニマテック株式会社 含フッ素ピラゾール化合物およびその製造方法

Also Published As

Publication number Publication date
EP4317154A1 (en) 2024-02-07
WO2022202537A1 (ja) 2022-09-29
CN117043158A (zh) 2023-11-10

Similar Documents

Publication Publication Date Title
BR112023012656A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
JPWO2022202537A1 (ja)
BR112023016292A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021016375A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015220A2 (ja)
BR102021015247A2 (ja)
BR102021014056A2 (ja)
BR102021012571A2 (ja)
BR102021012230A2 (ja)
BR102021012107A2 (ja)
BR102021010467A2 (ja)
BR102021009555A2 (ja)
BR102021009475A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230912